DAVIDsTEA Inc.: Nasdaq/NYSE listing notice — DAVIDsTEA to voluntarily delist from Nasdaq, list on TSX Venture Exchange starting April 3

DAVIDsTEA Inc.

Company to delist from Nasdaq effective close of markets on April 14, 2023 due to non-compliance with $1.00 bid price rule.
Common shares to commence trading on TSX Venture Exchange on April 3, 2023 under same symbol 'DTEA' in Canadian dollars.
Intends to file Form 15 with SEC around April 17 to suspend reporting obligations and deregister securities.
Decision driven by inability to regain compliance and desire to reduce administrative costs and regulatory burden.
Strategy and operations unchanged; all retail stores and majority of revenues are in Canada.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

DAVIDsTEA Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5550(a)(2)

Exact text from the filing

April 26, 2023, to regain compliance with the Bid Price Rule. Since receipt of the Letter, the Company’s management has reviewed its options in order to regain compliance with Nasdaq’s listing rules. However, management believes that it will not be able to regain compliance by the required deadline as set forth in the Letter. As a result, after careful consideration, the Board has determined it is in the overall best interests of the Company to delist its common shares from Nasdaq. The decision was made based on several factors, including the Board’s assessment of the probability of the Compa

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001477932-23-001753

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.